An automated instrument designed for the synthesis of oligonucleotides structurally similar to DNA or RNA. Generally used in solid-phase synthesis, one nucleotide is added to the extended oligonucleotide chain each time, and each nucleotide is added using the same chemical reaction with the corresponding purine or pyrimidine base derivative effect. The chemistry used and the details of the operation vary from instrument to instrument, but the most widely used method is the phosphoamide method for DNA synthesis.
The global market for DNA And RNA Synthesis Equipment was estimated to be worth US$ 1457 million in 2023 and is forecast to a readjusted size of US$ 2301.1 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA And RNA Synthesis Equipment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of DNA And RNA Synthesis Equipment by region & country, by Type, and by Application.
The DNA And RNA Synthesis Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA And RNA Synthesis Equipment.
麻豆原创 Segmentation
By Company
Beckman Coulter
ACTGene
Precision System Science
CSBio
Genscript Biotech
Protein Technologies
Applied Biosystems
K&A Labs GmbH
General Electric
Thermo Fisher Scientific
Tekna Plasma Systems
BioAutomation Corporation
Polygen GmbH
GlobalSpec
Biolytic Lab Performance
Segment by Type:
12 Channels
192 Channels
768 Channels
Segment by Application
Academic Institution
Research Center
Pharmaceutical Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA And RNA Synthesis Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of DNA And RNA Synthesis Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of DNA And RNA Synthesis Equipment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 DNA And RNA Synthesis Equipment Product Introduction
1.2 Global DNA And RNA Synthesis Equipment 麻豆原创 Size Forecast
1.2.1 Global DNA And RNA Synthesis Equipment Sales Value (2019-2030)
1.2.2 Global DNA And RNA Synthesis Equipment Sales Volume (2019-2030)
1.2.3 Global DNA And RNA Synthesis Equipment Sales Price (2019-2030)
1.3 DNA And RNA Synthesis Equipment 麻豆原创 Trends & Drivers
1.3.1 DNA And RNA Synthesis Equipment Industry Trends
1.3.2 DNA And RNA Synthesis Equipment 麻豆原创 Drivers & Opportunity
1.3.3 DNA And RNA Synthesis Equipment 麻豆原创 Challenges
1.3.4 DNA And RNA Synthesis Equipment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA And RNA Synthesis Equipment Players Revenue Ranking (2023)
2.2 Global DNA And RNA Synthesis Equipment Revenue by Company (2019-2024)
2.3 Global DNA And RNA Synthesis Equipment Players Sales Volume Ranking (2023)
2.4 Global DNA And RNA Synthesis Equipment Sales Volume by Company Players (2019-2024)
2.5 Global DNA And RNA Synthesis Equipment Average Price by Company (2019-2024)
2.6 Key Manufacturers DNA And RNA Synthesis Equipment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers DNA And RNA Synthesis Equipment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of DNA And RNA Synthesis Equipment
2.9 DNA And RNA Synthesis Equipment 麻豆原创 Competitive Analysis
2.9.1 DNA And RNA Synthesis Equipment 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by DNA And RNA Synthesis Equipment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA And RNA Synthesis Equipment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 12 Channels
3.1.2 192 Channels
3.1.3 768 Channels
3.2 Global DNA And RNA Synthesis Equipment Sales Value by Type
3.2.1 Global DNA And RNA Synthesis Equipment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA And RNA Synthesis Equipment Sales Value, by Type (2019-2030)
3.2.3 Global DNA And RNA Synthesis Equipment Sales Value, by Type (%) (2019-2030)
3.3 Global DNA And RNA Synthesis Equipment Sales Volume by Type
3.3.1 Global DNA And RNA Synthesis Equipment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global DNA And RNA Synthesis Equipment Sales Volume, by Type (2019-2030)
3.3.3 Global DNA And RNA Synthesis Equipment Sales Volume, by Type (%) (2019-2030)
3.4 Global DNA And RNA Synthesis Equipment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic Institution
4.1.2 Research Center
4.1.3 Pharmaceutical Company
4.1.4 Others
4.2 Global DNA And RNA Synthesis Equipment Sales Value by Application
4.2.1 Global DNA And RNA Synthesis Equipment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA And RNA Synthesis Equipment Sales Value, by Application (2019-2030)
4.2.3 Global DNA And RNA Synthesis Equipment Sales Value, by Application (%) (2019-2030)
4.3 Global DNA And RNA Synthesis Equipment Sales Volume by Application
4.3.1 Global DNA And RNA Synthesis Equipment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global DNA And RNA Synthesis Equipment Sales Volume, by Application (2019-2030)
4.3.3 Global DNA And RNA Synthesis Equipment Sales Volume, by Application (%) (2019-2030)
4.4 Global DNA And RNA Synthesis Equipment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global DNA And RNA Synthesis Equipment Sales Value by Region
5.1.1 Global DNA And RNA Synthesis Equipment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA And RNA Synthesis Equipment Sales Value by Region (2019-2024)
5.1.3 Global DNA And RNA Synthesis Equipment Sales Value by Region (2025-2030)
5.1.4 Global DNA And RNA Synthesis Equipment Sales Value by Region (%), (2019-2030)
5.2 Global DNA And RNA Synthesis Equipment Sales Volume by Region
5.2.1 Global DNA And RNA Synthesis Equipment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global DNA And RNA Synthesis Equipment Sales Volume by Region (2019-2024)
5.2.3 Global DNA And RNA Synthesis Equipment Sales Volume by Region (2025-2030)
5.2.4 Global DNA And RNA Synthesis Equipment Sales Volume by Region (%), (2019-2030)
5.3 Global DNA And RNA Synthesis Equipment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America DNA And RNA Synthesis Equipment Sales Value, 2019-2030
5.4.2 North America DNA And RNA Synthesis Equipment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe DNA And RNA Synthesis Equipment Sales Value, 2019-2030
5.5.2 Europe DNA And RNA Synthesis Equipment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific DNA And RNA Synthesis Equipment Sales Value, 2019-2030
5.6.2 Asia Pacific DNA And RNA Synthesis Equipment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America DNA And RNA Synthesis Equipment Sales Value, 2019-2030
5.7.2 South America DNA And RNA Synthesis Equipment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa DNA And RNA Synthesis Equipment Sales Value, 2019-2030
5.8.2 Middle East & Africa DNA And RNA Synthesis Equipment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA And RNA Synthesis Equipment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA And RNA Synthesis Equipment Sales Value
6.2.1 Key Countries/Regions DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.2.2 Key Countries/Regions DNA And RNA Synthesis Equipment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.3.2 United States DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.4.2 Europe DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.5.2 China DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.6.2 Japan DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.7.2 South Korea DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.8.2 Southeast Asia DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA And RNA Synthesis Equipment Sales Value, 2019-2030
6.9.2 India DNA And RNA Synthesis Equipment Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA And RNA Synthesis Equipment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Beckman Coulter
7.1.1 Beckman Coulter Company Information
7.1.2 Beckman Coulter Introduction and Business Overview
7.1.3 Beckman Coulter DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Beckman Coulter DNA And RNA Synthesis Equipment Product Offerings
7.1.5 Beckman Coulter Recent Development
7.2 ACTGene
7.2.1 ACTGene Company Information
7.2.2 ACTGene Introduction and Business Overview
7.2.3 ACTGene DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ACTGene DNA And RNA Synthesis Equipment Product Offerings
7.2.5 ACTGene Recent Development
7.3 Precision System Science
7.3.1 Precision System Science Company Information
7.3.2 Precision System Science Introduction and Business Overview
7.3.3 Precision System Science DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Precision System Science DNA And RNA Synthesis Equipment Product Offerings
7.3.5 Precision System Science Recent Development
7.4 CSBio
7.4.1 CSBio Company Information
7.4.2 CSBio Introduction and Business Overview
7.4.3 CSBio DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 CSBio DNA And RNA Synthesis Equipment Product Offerings
7.4.5 CSBio Recent Development
7.5 Genscript Biotech
7.5.1 Genscript Biotech Company Information
7.5.2 Genscript Biotech Introduction and Business Overview
7.5.3 Genscript Biotech DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Genscript Biotech DNA And RNA Synthesis Equipment Product Offerings
7.5.5 Genscript Biotech Recent Development
7.6 Protein Technologies
7.6.1 Protein Technologies Company Information
7.6.2 Protein Technologies Introduction and Business Overview
7.6.3 Protein Technologies DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Protein Technologies DNA And RNA Synthesis Equipment Product Offerings
7.6.5 Protein Technologies Recent Development
7.7 Applied Biosystems
7.7.1 Applied Biosystems Company Information
7.7.2 Applied Biosystems Introduction and Business Overview
7.7.3 Applied Biosystems DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Applied Biosystems DNA And RNA Synthesis Equipment Product Offerings
7.7.5 Applied Biosystems Recent Development
7.8 K&A Labs GmbH
7.8.1 K&A Labs GmbH Company Information
7.8.2 K&A Labs GmbH Introduction and Business Overview
7.8.3 K&A Labs GmbH DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 K&A Labs GmbH DNA And RNA Synthesis Equipment Product Offerings
7.8.5 K&A Labs GmbH Recent Development
7.9 General Electric
7.9.1 General Electric Company Information
7.9.2 General Electric Introduction and Business Overview
7.9.3 General Electric DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 General Electric DNA And RNA Synthesis Equipment Product Offerings
7.9.5 General Electric Recent Development
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Information
7.10.2 Thermo Fisher Scientific Introduction and Business Overview
7.10.3 Thermo Fisher Scientific DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Thermo Fisher Scientific DNA And RNA Synthesis Equipment Product Offerings
7.10.5 Thermo Fisher Scientific Recent Development
7.11 Tekna Plasma Systems
7.11.1 Tekna Plasma Systems Company Information
7.11.2 Tekna Plasma Systems Introduction and Business Overview
7.11.3 Tekna Plasma Systems DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Tekna Plasma Systems DNA And RNA Synthesis Equipment Product Offerings
7.11.5 Tekna Plasma Systems Recent Development
7.12 BioAutomation Corporation
7.12.1 BioAutomation Corporation Company Information
7.12.2 BioAutomation Corporation Introduction and Business Overview
7.12.3 BioAutomation Corporation DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 BioAutomation Corporation DNA And RNA Synthesis Equipment Product Offerings
7.12.5 BioAutomation Corporation Recent Development
7.13 Polygen GmbH
7.13.1 Polygen GmbH Company Information
7.13.2 Polygen GmbH Introduction and Business Overview
7.13.3 Polygen GmbH DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Polygen GmbH DNA And RNA Synthesis Equipment Product Offerings
7.13.5 Polygen GmbH Recent Development
7.14 GlobalSpec
7.14.1 GlobalSpec Company Information
7.14.2 GlobalSpec Introduction and Business Overview
7.14.3 GlobalSpec DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.14.4 GlobalSpec DNA And RNA Synthesis Equipment Product Offerings
7.14.5 GlobalSpec Recent Development
7.15 Biolytic Lab Performance
7.15.1 Biolytic Lab Performance Company Information
7.15.2 Biolytic Lab Performance Introduction and Business Overview
7.15.3 Biolytic Lab Performance DNA And RNA Synthesis Equipment Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Biolytic Lab Performance DNA And RNA Synthesis Equipment Product Offerings
7.15.5 Biolytic Lab Performance Recent Development
8 Industry Chain Analysis
8.1 DNA And RNA Synthesis Equipment Industrial Chain
8.2 DNA And RNA Synthesis Equipment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA And RNA Synthesis Equipment Sales Model
8.5.2 Sales Channel
8.5.3 DNA And RNA Synthesis Equipment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Beckman Coulter
ACTGene
Precision System Science
CSBio
Genscript Biotech
Protein Technologies
Applied Biosystems
K&A Labs GmbH
General Electric
Thermo Fisher Scientific
Tekna Plasma Systems
BioAutomation Corporation
Polygen GmbH
GlobalSpec
Biolytic Lab Performance
听
听
*If Applicable.
